【摘要】 目的　评价参麦注射液治疗AMI的临床疗效。方法　 137例AMI患者随机分成参麦注射液治疗组 (n =4 1)和对照组 (n =96 )。治疗组在常规治疗基础上加用参麦注射液 4 0～ 6 0ml溶于 5 %葡糖 2 5 0ml或 0 .85盐水 2 5 0ml中 ,每日一次静脉滴入 ,10～ 15d为一疗程。观察住院期间的死亡率、心力衰竭和心源性休克发生率。结果　治疗组死亡率、心衰及心源性休克发生率均明显低于对照组。结论　参麦注射液能够明显降低AMI患者住院死亡率 ,明显改善AMI患者心功能 ,降低心力衰竭及心源性休克的发生率。更多还原

【Abstract】 Objective: To evaluate the effect of Shen Mai in patients with Acute Myocardia Infarction (AMI).Methods:137 cases with AMI were divided into Shen Mai group (n=41) and control gronp (n=96) respectively.on the basis of traditional treatment, Shen Mai group were also treated with Shen Mai ,which was 40～60 ml/d for 10～15days. Mortality, heart failure rate and heart shock rate were observed in the course of hospital.Results: Mortality, heart failure rate and heart shock rate in ShenMai group were all lower than that in control group.Conclusions: Shen Mai treated in patients with AMI can significantly decreased the mortality ,imnprove the heart funcfion, and decreased heart failure rate and heart shock rate.更多还原